Related references
Note: Only part of the references are listed.A Clinical Trial of Combination Therapy with Etanercept and Low Dose Cyclosporine for the Treatment of Refractory Psoriasis
Eun Ju Lee et al.
ANNALS OF DERMATOLOGY (2010)
Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the UK
K. Abuabara et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Infliximab monotherapy in Japanese patients with moderate-to-severe plaque psoriasis and psoriatic arthritis. A randomized, double-blind, placebo-controlled multicenter trial
Hideshi Torii et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2010)
Adalimumab in Japanese patients with moderate to severe chronic plaque psoriasis: Efficacy and safety results from a Phase II/III randomized controlled study
Akihiko Asahina et al.
JOURNAL OF DERMATOLOGY (2010)
Cardiovascular Disease and Risk Factors in Patients with Psoriasis and Psoriatic Arthritis
Anne-Marie Tobin et al.
JOURNAL OF RHEUMATOLOGY (2010)
Combining etanercept with traditional agents in the treatment of psoriasis: a review of the clinical evidence
P. A. Foley et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2010)
Better short-term clinical response to etanercept in Chinese than Caucasian patients with active ankylosing spondylitis
Chung-Tei Chou et al.
MODERN RHEUMATOLOGY (2010)
Combining Traditional Systemic and Biologic Therapies for Psoriasis
Michael P. Heffernan
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY (2010)
Comparison of MHC class I risk haplotypes in Thai and Caucasian psoriatics shows locus heterogeneity at PSORS1
P. E. Stuart et al.
TISSUE ANTIGENS (2010)
Comparison of two etanercept regimens for treatment of psoriasis and psoriatic arthritis: PRESTA randomised double blind multicentre trial
Wolfram Sterry et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Biologic therapies for psoriasis: practical experience in a UK tertiary referral centre
R. B. Warren et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome
R. J. B. Driessen et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Etanercept in severe, recalcitrant psoriasis: clinical response, safety profile and predictors of response based on a single institution's experience
C. Antoniou et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2009)
Etanercept: Efficacy and safety
R. Jimenez-Puya et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2009)
The combination of etanercept and methotrexate increases the effectiveness of treatment in active psoriasis despite inadequate effect of methotrexate therapy
Claus Zachariae et al.
ACTA DERMATO-VENEREOLOGICA (2008)
Effectiveness of the combination of a whole-blood interferon-gamma assay and the tuberculin skin test in detecting latent tuberculosis infection in rheumatoid arthritis patients receiving adalimumab therapy
Der-Yuan Chen et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Etanercept combined with methotrexate for high-need psoriasis
R. J. B. Driessen et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Low-dose etanercept therapy in moderate to severe psoriasis in Korean
Jung Im Na et al.
JOURNAL OF DERMATOLOGY (2008)
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial
Alan Menter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Clinical effectiveness and safety experience with efalizumab in the treatment of patients with moderate-to-severe plaque psoriasis in Taiwan: results of an open-label, single-arm pilot study
T. F. Tsai et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2008)
Clinical effectiveness and safety experience with alefacept in the treatment of patients with moderate-to-severe chronic plaque psoriasis in Taiwan: results of an open-label, single-arm, multicentre pilot study
P. H. Huang et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2008)
Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION)
J. -H. Saurat et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
CLINICAL EXPERIENCE WITH ETANERCEPT IN THE TREATMENT OF PSORIASIS
B. Martin et al.
ACTAS DERMO-SIFILIOGRAFICAS (2008)
Two years of experience with etanercept in recalcitrant psoriasis
K. Ahmad et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis
Stephen Tyring et al.
ARCHIVES OF DERMATOLOGY (2007)
Initial experience with routine administration of etanercept in psoriasis
M. de Groot et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
Patients with psoriasis respond to continuous open-label etanercept treatment after initial incomplete response in a randomized, placebo-controlled trial
GG Krueger et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Use of etanercept for psoriatic arthritis in the dermatology clinic: The Experience Diagnosing, Understanding Care, and Treatment with Etanercept (EDUCATE) study
Alice B. Gottlieb et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2006)
Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial
K Reich et al.
LANCET (2005)
A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction
KA Papp et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis
J Brandt et al.
RHEUMATOLOGY (2005)
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial
L Klareskog et al.
LANCET (2004)
Thrombogenicity of TNFα in rheumatoid arthritis defined through biological probes:: TNFα blockers
G Ferraccioli et al.
AUTOIMMUNITY REVIEWS (2004)
Efalizumab for patients with moderate to severe plaque psoriasis - A randomized controlled trial
KB Gordon et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
A randomized trial of etanercept as monotherapy for psoriasis
AB Gottlieb et al.
ARCHIVES OF DERMATOLOGY (2003)
Etanercept as monotherapy in patients with psoriasis
CL Leonardi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis
M Lebwohl et al.
ARCHIVES OF DERMATOLOGY (2003)
A study of candidate genes for psoriasis near HLA-C in Chinese patients with psoriasis
YT Chang et al.
BRITISH JOURNAL OF DERMATOLOGY (2003)
Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial
U Chaudhari et al.
LANCET (2001)
Share Paper
